found no correlation between tumour size and positive lymph node status among carriers of the breast cancer ( BRCA ) 1 gene, although there was a highly significant correlation between these variables among BRCA2 carriers and both BRCA1 and BRCA2 non-carriers. 20 Overall, pCR to treatment (i.e. the absence of residual disease in the primary site as well in the recovered lymph nodes) is an important endpoint when determining NAC treatment efficacy for advanced
← all excerpts
Outcomes of Women with Non-Metastatic Triple-Negative Breast Cancer in Oman: A single-centre experience.
1
—
—